Used in pharmaceutical research as a key intermediate in the synthesis of selective kinase inhibitors, particularly targeting enzymes involved in inflammatory and oncogenic pathways. Its structural features enable strong binding to specific protein targets, making it valuable in developing treatments for cancer and autoimmune diseases. The compound's chirality enhances selectivity, reducing off-target effects in drug candidates. It is also employed in structure-activity relationship (SAR) studies to optimize potency and pharmacokinetic properties of new therapeutic agents.